Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wenman Wu

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
Thrombosis Research|April 17, 2026
Pseudoexon inclusion induced by three deep intronic variants in hemophilia B and correction achieved through an antisense oligonucleotide-based strategyGuangming Chen, Jialu Zhang, Liya Lin, et al.
Chemical Biology & Drug Design|May 21, 2019
An unexpected dynamic binding mode between coagulation factor X and Rivaroxaban reveals importance of flexibility in drug bindingSi-Ying Qu, Qin Xu, Wenman Wu, et al.
Zhonghua Yi Xue Yi Chuan Xue Za Zhi = Zhonghua Yixue Yichuanxue Zazhi = Chinese Journal of Medical Genetics|March 29, 2005
[Inherited dysfibrinogenemia caused by Arg275His in the beta chain of fibrinogen]Yi Fang, Xuefeng Wang, Hua Qi, et al.
Human Mutation|December 9, 2021
Unraveling the molecular basis underlying nine putative splice site variants of von Willebrand factorQian Liang, Xiaoyi Lin, Xi Wu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 17, 2025
Correction of VWF multimerization in type 2A/IIC von Willebrand disease by exogenous VWF propeptide supplementationZiqi Zhang, Qian Liang, Xiaoqian Xu, et al.
Haematologica|July 10, 2025
Perioperative management of total hip arthroplasty in hemophilia A following gene therapyYanyan Shao, Chuanlong Wu, Wei Liu, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 27, 2019
Prothrombin Arg541Trp Mutation Leads to Defective PC (Protein C) Pathway Activation and Constitutes a Novel Genetic Risk Factor for Venous ThrombosisXi Wu, Jing Dai, Xiaoqian Xu, et al.
Journal of Thrombosis and Haemostasis : JTH|June 11, 2026
Trp83 is vital to the interaction with phospholipids in Gla domain of protein CJunwei Yuan, Shijie Zhou, Xi Wu, et al.
The Journal of Biological Chemistry|April 29, 2008
Factor XI homodimer structure is essential for normal proteolytic activation by factor XIIa, thrombin, and factor XIaWenman Wu, Dipali Sinha, Sergei Shikov, et al.
Journal of Thrombosis and Haemostasis : JTH|May 24, 2024
Met343Val mutation disrupts the shuttling of Trp380 leading to a low-activity conformer of activated protein C and causes thrombosisShijie Zhou, Fang Li, Zhe Lai, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Thrombosis Research|April 17, 2026
Pseudoexon inclusion induced by three deep intronic variants in hemophilia B and correction achieved through an antisense oligonucleotide-based strategyGuangming Chen, Jialu Zhang, Liya Lin, et al.
Chemical Biology & Drug Design|May 21, 2019
An unexpected dynamic binding mode between coagulation factor X and Rivaroxaban reveals importance of flexibility in drug bindingSi-Ying Qu, Qin Xu, Wenman Wu, et al.
Zhonghua Yi Xue Yi Chuan Xue Za Zhi = Zhonghua Yixue Yichuanxue Zazhi = Chinese Journal of Medical Genetics|March 29, 2005
[Inherited dysfibrinogenemia caused by Arg275His in the beta chain of fibrinogen]Yi Fang, Xuefeng Wang, Hua Qi, et al.
Human Mutation|December 9, 2021
Unraveling the molecular basis underlying nine putative splice site variants of von Willebrand factorQian Liang, Xiaoyi Lin, Xi Wu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 17, 2025
Correction of VWF multimerization in type 2A/IIC von Willebrand disease by exogenous VWF propeptide supplementationZiqi Zhang, Qian Liang, Xiaoqian Xu, et al.
Haematologica|July 10, 2025
Perioperative management of total hip arthroplasty in hemophilia A following gene therapyYanyan Shao, Chuanlong Wu, Wei Liu, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 27, 2019
Prothrombin Arg541Trp Mutation Leads to Defective PC (Protein C) Pathway Activation and Constitutes a Novel Genetic Risk Factor for Venous ThrombosisXi Wu, Jing Dai, Xiaoqian Xu, et al.
Journal of Thrombosis and Haemostasis : JTH|June 11, 2026
Trp83 is vital to the interaction with phospholipids in Gla domain of protein CJunwei Yuan, Shijie Zhou, Xi Wu, et al.
The Journal of Biological Chemistry|April 29, 2008
Factor XI homodimer structure is essential for normal proteolytic activation by factor XIIa, thrombin, and factor XIaWenman Wu, Dipali Sinha, Sergei Shikov, et al.
Journal of Thrombosis and Haemostasis : JTH|May 24, 2024
Met343Val mutation disrupts the shuttling of Trp380 leading to a low-activity conformer of activated protein C and causes thrombosisShijie Zhou, Fang Li, Zhe Lai, et al.
Pageof 6